SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PTC Therapeutics -- PTCT
An SI Board Since January 2014
Posts SubjectMarks Bans Symbol
38 7 0 PTCT
Emcee:  scaram(o)uche Type:  Moderated
Min  Hr  Day  Wk  Mon  Yr  3 Yr  Log
Introduction Market Data Compact
PTCT 68.47+0.5%11:52 AM EDT
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
38Good........ thestreet.comscaram(o)uche-2/27/2016
37BMI-1 inhibitor (PTC596) trial is now recruiting, starting at 0.65 mg/kg...... scaram(o)uche-7/30/2015
36I've continued to watch for ataluren-related publications. Nada. One wouldscaram(o)uche-6/24/2015
35There is an entire crew of twitter jerks with high school biology backgrounds (oscaram(o)uche-4/17/2015
34Heads up.... that's old news that I had missed. Looks like others had as scaram(o)uche-4/16/2015
33How he found them, I'll never know. Been looking for an hour. But Andy Bioscaram(o)uche-4/16/2015
32There is an ever-increasing number of biotech investors who believe that theyscaram(o)uche-4/8/2015
31Epigenetics. 2015 Apr 1:0. [Epub ahead of print] A novel Werner Syndrome mutatiscaram(o)uche-4/7/2015
30Certain everyone knows this, but here's the story.... ncbi.nlm.nih.gov ncbscaram(o)uche-2/24/2015
29>> Perhaps some of them are doubling down << oooooops!scaram(o)uche-2/24/2015
28launched.... clinicaltrials.gov rumor..... fiercebiotech.com Twitter gang, oscaram(o)uche-2/23/2015
27Sudden burst of covering? Or? Volatility out of blue..... (heh!.... timely scaram(o)uche-12/9/2014
26Two "progress in pipe" bullets from the recent corporate update, incluscaram(o)uche-11/18/2014
25>> The previously announced underwritten public offering of 3,450,000 sharscaram(o)uche110/16/2014
24just parking for future reference..... 22 May 2014 EMA/369266/2014 Committee scaram(o)uche-10/8/2014
23>> to me the SMA program is what I find most interesting << Wo! Phscaram(o)uche-10/8/2014
22Hey Maurice. I'm a case-specific hater. sec.gov (open market dump, $15.14scaram(o)uche-10/8/2014
21I'm not a fan or hater of Martin actually :-). I think when he was CEO he bghmm-10/8/2014
20And now? TKMR (ARWR competitor, except that ARWR is obviously, now, not a comscaram(o)uche-10/8/2014
19>> so simple, pointing to crappy biotechs << Somewhere around here,scaram(o)uche-10/8/2014
18I haven't noticed that he's smart. I've noticed that he can increasscaram(o)uche-10/7/2014
17Martin is a smart guy (much more than me) and seems to know his stuff well. He ghmm-10/7/2014
16Martin Shkreli @MartinShkreli · Oct 2 oh yeah i'm short $PTCT. that tscaram(o)uche-10/7/2014
15Cowen downgrades to market perform, PT of 45. Off about 9% as I type. Everyonescaram(o)uche-10/6/2014
14PTC Therapeutics Receives Conditional Approval in the European Union for Translascaram(o)uche-8/4/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News